Get Premium to unlock powerful stock data
Mustang Bio Inc logo

Mustang Bio Inc

$ 0.69 +0.0291 (+4.4%) 10:08 PM EST
P/E:
At Loss
P/B:
0.72
Market Cap:
$ 71.17M
Enterprise V:
$ -22.11M
Volume:
628.67K
Avg Vol (2M):
807.50K
Also Trade In:
Volume:
628.67K
Market Cap $:
71.17M
PE Ratio:
At Loss
Avg Vol (2-Month):
807.50K
Enterprise Value $:
-22.11M
PB Ratio:
0.72
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Mustang Bio Inc
NAICS : 325414 SIC : 2836
377 Plantation Street, Worcester, MA, USA, 01605
Description
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 4.22
Equity-to-Asset 0.71
Debt-to-Equity 0.3
Debt-to-EBITDA -0.42
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.9
9-Day RSI 47.37
14-Day RSI 44.83
6-1 Month Momentum % -64.26
12-1 Month Momentum % -77.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.51
Quick Ratio 11.51
Cash Ratio 11.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -50.7

Financials (Next Earnings Date:2022-08-16 Est.)

MBIO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MBIO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.77
Beta 1.5
Volatility % 48.88
14-Day RSI 44.83
14-Day ATR ($) 0.074619
20-Day SMA ($) 0.693945
12-1 Month Momentum % -77.81
52-Week Range ($) 0.614 - 4.06
Shares Outstanding (Mil) 103.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mustang Bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More